BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 120 filers reported holding BIOSCRIP INC in Q3 2016. The put-call ratio across all filers is 0.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $218,000 | 0.0% | 83,998 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $218,000 | +52.4% | 83,998 | +17.5% | 0.01% | +30.0% |
| Q1 2019 | $143,000 | -40.4% | 71,501 | +6.2% | 0.01% | -52.4% |
| Q4 2018 | $240,000 | +421.7% | 67,333 | +355.0% | 0.02% | +600.0% |
| Q3 2018 | $46,000 | +7.0% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $43,000 | +19.4% | 14,800 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $36,000 | -16.3% | 14,800 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $43,000 | -18.9% | 14,800 | -22.9% | 0.00% | -33.3% |
| Q3 2017 | $53,000 | +1.9% | 19,200 | 0.0% | 0.01% | -14.3% |
| Q2 2017 | $52,000 | +52.9% | 19,200 | -5.0% | 0.01% | +40.0% |
| Q1 2017 | $34,000 | -37.0% | 20,200 | +8.0% | 0.01% | -50.0% |
| Q3 2016 | $54,000 | +12.5% | 18,700 | 0.0% | 0.01% | -9.1% |
| Q2 2016 | $48,000 | +54.8% | 18,700 | +29.9% | 0.01% | +37.5% |
| Q1 2016 | $31,000 | – | 14,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |